We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+11.14%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$12B
AUM Growth
+$69.7M
Cap. Flow
-$563M
Cap. Flow %
-4.69%
Top 10 Hldgs %
9.41%
Holding
3,421
New
503
Increased
814
Reduced
1,004
Closed
881

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$139M
2
LULU icon
lululemon athletica
LULU
+$118M
3
V icon
Visa
V
+$100M
4
DPZ icon
Domino's
DPZ
+$91.8M
5
TTWO icon
Take-Two Interactive
TTWO
+$86.8M

Top Sells

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$73.8M
2
T icon
AT&T
T
+$57.2M
3
MA icon
Mastercard
MA
+$54.8M
4
EXPE icon
Expedia Group
EXPE
+$50.8M
5
JPM icon
JPMorgan Chase
JPM
+$49.7M

Sector Composition

Rank Sector Weight
1 Financials 19.99%
2 Consumer Discretionary 16.81%
3 Technology 13.53%
4 Industrials 10.21%
5 Healthcare 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
2926
PTC Therapeutics
PTCT
$6.12B
-5,745
Closed -$289K
PTGX icon
2927
Protagonist Therapeutics
PTGX
$9.44B
-31,814
Closed -$268K
PUBM icon
2928
PubMatic
PUBM
$810M
-258,222
Closed -$4.29M
PUMP icon
2929
ProPetro Holding
PUMP
$1.35B
-79,500
Closed -$640K
PVL
2930
Permianville Royalty Trust
PVL
$57.1M
-15,500
Closed -$52K
PWR icon
2931
Quanta Services
PWR
$101B
-21,328
Closed -$2.72M
PYPL icon
2932
PUT
PayPal
PYPL
$50.5B
-146,200
Closed -$995K
QDEL icon
2933
QuidelOrtho
QDEL
$838M
-25,585
Closed -$1.83M
QNCX icon
2934
Quince Therapeutics
QNCX
$29.5M
-137
Closed -$36K
QQQ icon
2935
CALL
Invesco QQQ Trust
QQQ
$484B
-315,000
Closed -$3.31M
QQQ icon
2936
Invesco QQQ Trust
QQQ
$484B
-56,085
Closed -$15M
QQQ icon
2937
PUT
Invesco QQQ Trust
QQQ
$484B
-250,000
Closed -$1.79M
QTWO icon
2938
Q2 Holdings
QTWO
$3.92B
-7,050
Closed -$228K
RAMP icon
2939
LiveRamp
RAMP
$2.3B
-12,500
Closed -$228K
RDFN
2940
DELISTED
Redfin
RDFN
-311,900
Closed -$1.82M
REGN icon
2941
Regeneron Pharmaceuticals
REGN
$80.8B
-5,380
Closed -$3.71M
RELX icon
2942
RELX
RELX
$62B
-34,600
Closed -$841K
RGNX icon
2943
Regenxbio
RGNX
$708M
-7,578
Closed -$200K
RGP icon
2944
Resources Connection
RGP
$145M
-11,300
Closed -$204K
RLJ icon
2945
RLJ Lodging Trust
RLJ
$1.69B
-80,719
Closed -$816K
RNAC icon
2946
Cartesian Therapeutics
RNAC
$268M
-510
Closed -$25K
RNST icon
2947
Renasant Corp
RNST
$3.91B
-18,835
Closed -$589K
RNW icon
2948
ReNew
RNW
$2.25B
-46,600
Closed -$280K
ROG icon
2949
PUT
Rogers Corp
ROG
$2.4B
-1,200
Closed -$4K
RSP icon
2950
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
-30,700
Closed -$3.91M

Similar funds

Schonfeld Strategic Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Schonfeld Strategic Advisors held 3,421 positions worth $12B, up 0.58% from $11.9B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Schonfeld Strategic Advisors withdrew a net $563M in Q4 2022, closing 881 positions and reducing 1,004 holdings. Its most notable exit was Duke Realty Corp., an estimated $46.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Schonfeld Strategic Advisors opened a new position in Denbury Inc. worth $64.5M.

  • Schonfeld Strategic Advisors's largest Q4 2022 buy was Denbury Inc.: 740,800 shares worth $64.5M.
  • Schonfeld Strategic Advisors added most to Ferguson in Q4 2022, an estimated $139M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2022 reduction was Fidelity National Information Services, cutting an estimated $73.8M.
  • Schonfeld Strategic Advisors fully exited Duke Realty Corp. in Q4 2022, selling an estimated $46.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 9.4% of its $12B portfolio in Q4 2022.
  • Schonfeld Strategic Advisors opened 503 new positions and closed 881 in Q4 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 0.58% quarter-over-quarter to $12B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.